Mordor Intelligence™ provides comprehensive insights into Syneos Health. Gain valuable industry research and analysis in this detailed company report.
Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and twelve months ended December 31, 2020.
MORRISVILLE, N.C., April 29, 2021 (GLOBE NEWSWIRE) — Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today reported financial results for the three months ended March 31, 2021.“We delivered strong first quarter results and returned to year-over-...
“I am incredibly honored to take on this role and lead Syneos Health and our talented colleagues around the world,” Keefe said. “I want to thank Alistair for his partnership and guidance these past four plus years, and I appreciate the support from the Board. Syneos Health holds a ...
EY serves clients in various sectors including financial services, healthcare, technology, and government. It was founded in 1989 and is based in London, United Kingdom. C Care Access Care Access operates as a global research site. It specializes in accelerating the availability of new medical ...
Work Here Matters Everywhere Each day, you’ll be reminded about why you chose a career in healthcare. The work is challenging. The pace is exhilarating. The people – your colleagues and our customers – are inspiring. Find your career...
Screen on your Watchlists and Portfolios with Barchart Plus.FREE 30 Day Trial Syneos Health Inc(SYNH) 42.98+0.01(+0.02%)09/28/23[NASDAQ] Snapshot Chartfor Wed, Sep 27th, 2023 Help Apply Template None Save Chart 1-Day 5-Day 1-Mth 3-Mth 6-Mth 1-Yr 5-Yr 20-Yr...
Syneos Health Inc(SYNH) 42.98+0.01(+0.02%)09/28/23[NASDAQ] Analyst Ratingsfor Wed, Sep 27th, 2023 Help Analyst Target Prices HIGH TARGET MEAN TARGET LOW TARGET 52 WK High 52 WK Low Average Analyst Ratings 3 Mths Ago Hold 3.00
Post-pandemic budgetary pressures, coupled with the need to generate revenue for other priorities, have compelled policymakers to tighten the financial screws on the industry. Blog February 8, 2024 Lights! Cameras! But no action at Senate hearing on drug prices The Senate Health Education Labor ...
Syneos Health, Inc., the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporatio